In vivo stability evaluation of Mg substituted low crystallinity ß-tricalcium phosphate granules fabricated through dissolution-precipitation reaction for bone regeneration

Apatitic calcium phosphate /montmorillonite nano-biocomposite: in-situ synthesis, characterization and dissolution properties

Recently, calcium phosphate/montmorillonite composites have received attention as a synthetic bone substitutes. In this study, apatitic calcium phosphate/Montmorillonite nano-biocomposites were in-situ synthesized at 22 °C by reaction between calcium hydroxide and orthophosphoric acid in the presence of different contents of montmorillonite (MNa). Fourier Transform Infrared Spectroscopy (FTIR), X-ray Diffraction (XRD), Transmission Electron Microscopy (TEM) and Brunauer–Emmett–Teller (BET) surface areas were used to characterize the prepared powders. The XRD results show that the composites prepared with 2 and 5 wt% MNa and sintered at 900 °C, show the formation of hydroxyapatite (HAP) structure, whereas that prepared with 10 wt% MNa leads to the formation of β-tricalcium phosphate (β-TCP) structure. The HAP structure decomposes at 1000 °C and leads to the formation of biocomposite containing HAP, β and α-TCP. However, β-TCP composites show thermal stability. FTIR and structural refinement results show the incorporation of clay ions into the apatitic structure causing changes in the crystal structure of the formed calcium phosphate phases. The changes in the composition and structure lead to an increase in the dissolution rate of HAP and a decrease in that of β-TCP.

Strategies for advanced particulate bone substitutes regulating the osteo-immune microenvironment

The usage of bone substitute granule materials has improved the clinical results of alveolar bone deficiencies treatment and thus broadened applications in implant dentistry. However, because of the complicated mechanisms controlling the foreign body response, no perfect solution can avoid the fibrotic encapsulation of materials till now, which may impair the results of bone regeneration, even cause the implant materials rejection. Recently, the concept of 'osteoimmunology' has been stressed. The outcomes of bone regeneration are proved to be related to the bio-physicochemical properties of biomaterials, which allow them to regulate the biological behaviours of both innate and adaptive immune cells. With the development of single cell transcriptome, the truly heterogeneity of osteo-immune cells has been clarifying, which is helpful to overcome the limitations of traditional M1/M2 macrophage nomenclature and drive the advancements of particulate biomaterials applications. This review aims at introducing the mechanisms of optimal osseointegration regulated by immune systems and provides feasible strategies for the design of next generation 'osteoimmune-smart' particulate bone substitute materials in dental clinic.

Bioinorganic supplementation of calcium phosphate-based bone substitutes to improve in vivo performance: a systematic review and meta-analysis of animal studies

Supplementation of CaP-based bone graft substitutes with bioinorganics such as strontium, zinc or silicon is an interesting approach to increase the biological performance in terms of bone regenerative potential of calcium phosphate (CaP)-based bone substitutes. However, the in vivo efficacy of this approach has not been systematically analyzed, yet. Consequently, we performed a systematic review using the available literature regarding the effect of bioinorganic supplementation in CaP-based biomaterials on new bone formation and material degradation in preclinical animal bone defect models and studied this effect quantitatively by performing a meta-analysis. Additional subgroup analyses were used to study the effect of different bioinorganics, animal model, or phase category of CaP-based biomaterial on bone formation or material degradation. Results show that bioinorganic supplementation increases new bone formation (standardized mean difference [SMD]: 1.43 SD, confidence interval [CI]: 1.13-1.73). Additional subgroup analysis showed that strontium, magnesium and silica significantly enhanced bone formation, while zinc did not have any effect. This effect of bioinorganic supplementation on new bone formation was stronger for DCPD or β-TCP and biphasic CaPs than for HA or α-TCP (p < 0.001). In general, material degradation was slightly hindered by bioinorganic supplementation (mean difference [MD]: 0.84%, CI: 0.01-1.66), with the exception of strontium that significantly enhanced degradation. Overall, bioinorganic supplementation represents an effective approach to enhance the biological performance of CaP-based bone substitutes.